Calico / AbbVie collaboration announcement demonstrates growth of the Rejuvenation Biotechnology industryPosted by Mike Kope, CEO on September 04, 2014 | Outreach
Reuter's announced today the launch of a Calico/Abbvie agreement. SENS Research Foundation congratulates U.S. drugmaker AbbVie Inc and Calico on the excellent news of their collaboration.
SENS Research Foundation is pleased to announce that its Board has authorized a bridge loan to Arigos Biomedical, Inc.
The SENS6 conference was an amazing opportunity to engage in ongoing research in the field of biogerontology and regenerative medicine. I was really excited to attend a conference on such a scale and share the results of my 2013 summer research with Dr. Graca Almeida-Porada at the Wake Forest Institute for Regenerative Medicine with scientists from all over the world at the venerable University of Cambridge.
Attending the SENS6 conference was an awesome experience for me. Fascinating presentations about the latest advances in a wide range of regenerative medicine fields enthralled me from dawn till dusk. Each day was also punctuated by discussions about science and life experience, which usually continued deep into the night, and I can wholeheartedly say were no less informative than the scientific presentations themselves. I met a bunch of fellow students and researchers, who are also passionate about SRF’s mission. Finally, meeting well-known professors, whom I had previously only known through their publications, was a bit surreal to say the least.
On November 15th SENS Research Foundation announced its year-end giving campaign. To continue to increase our impact on advancing the field of regenerative medicine, we asked for help from our community. More funding will mean more researchers and more labs making cures for the diseases of aging a reality.
SENS6 Favorites: Reprogramming the immune system: Clinical trials at University of California. SRF Intern Ethan Sarnoski on talk by Matthew Scholz, founder and CEO of ImmusoftPosted by Iain Inkster on October 31, 2013 | SENS6
The following is an account of the 2013 SENS6: Reimagine Aging Conference at Queens' College.
SENS6 Favorites: Breakthrough Protocols to Study AGEs and Combat Viruses by Yale’s David Spiegel and MIT’s Todd RiderPosted by Iain Inkster on October 25, 2013 | SRF Education
The most amazing thing to me about the SENS conferences is their perennial appeal to the non-scientist. It’s interesting to see how many people from unrelated backgrounds come to watch highly technical talks on biochemistry, molecular biology, and regenerative medicine. This is most likely owing to the incredible advances in research being presented at the conference.
SENS6 Favorites: How small molecule intervention by the Chen and Madeo labs may reverse the aging processPosted by Iain Inkster on October 16, 2013 | SENS6
SENS6 Favorites: How small molecule intervention by the Chen and Madeo labs may reverse the aging process
Firsthand account of Dr. Rigdon Lentz's and Dr. Jean Hebert's SENS6 presentations by intern Ariana Mirzarafie-AhiPosted by Iain Inkster on October 10, 2013 | OncoSENS
Firsthand account of Dr. Rigdon Lentz's and Dr. Jean Hebert's SENS6 presentations by intern Ariana Mirzarafie-Ahi
Today, Larry Page announced that Apple and Genentech chair Art Levinson will lead Calico, a Google initiative focused on challenges of age-related disease. TIME asked SRF CSO Aubrey de Grey for his take, posted in conjunction with the breaking news.
Summary of the SENS6: Reimaging Aging Conference
As a research-based outreach organization, SENS Research Foundation couples its strong scientific programs with an important focus on spreading the word about its cause. That focus is the reason that we’re so excited to announce our new Reimagine Aging celebrity campaign.